A Step Closer to Personalised Medicine for Liver Fibrosis

Article   Jun 02, 2017 | By Anna MacDonald, Editor for Technology Networks

 
A Step Closer to Personalised Medicine for Liver Fibrosis

Anna MacDonald

Editor

 
 
 
 

RELATED ARTICLES

Key Challenges and Pain Points in the Global Laboratory Market

Article

To better understand the key challenges and pain points in the global laboratory market, Agilent commissioned Frost & Sullivan to carry out an independent survey of 700 scientists across the laboratory employee spectrum. Here we highlight a selection of the survey’s key findings.

READ MORE

Antibodies in Drug Discovery: Identifying Novel Biomarkers to Overcome Sjögren’s Syndrome

Article

New diagnostic tool could therefore lead to improved therapeutic success and a better quality of life for the millions of patients suffering from Sjögren’s syndrome around the world.

READ MORE

Applied Proteogenomics: A New Weapon in the War Against Cancer

Article

The complexities of tumor genomes are rapidly being uncovered, but how they are regulated into functional proteomes remains poorly understood, until now.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE